<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02363101</url>
  </required_header>
  <id_info>
    <org_study_id>INCA012015</org_study_id>
    <nct_id>NCT02363101</nct_id>
  </id_info>
  <brief_title>Health Outcomes and Costs (HOC) in Lung Cancer (LC)</brief_title>
  <acronym>HOC-LC</acronym>
  <official_title>Health Outcomes and Costs (HOC) in Brazilian Public Health Care System - The HOC Study in Lung Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Instituto Nacional de Cancer, Brazil</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Instituto Nacional de Cardiologia de Laranjeiras</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Instituto Nacional de Cancer, Brazil</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the costs, health-related quality of life and
      preference values from lung cancer patients assisted in a Brazilian public health care unit.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The costs will be assessed by micro-costing approach. All procedures involved in lung cancer
      at diagnosis, staging, treatment and best supportive care will be assessed.

      The health-related quality of life will be assessed by EORTC-QLQ-C30, EQ-5D and
      EORTC-QLQ-LC13 in all different stages of lung cancer.

      An utility measure will be considered. The preference values will be assessed via discrete
      choice experiment. Two scenarios will be designed and the lung cancer patients will be asked
      about the preferences.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>March 2015</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">March 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Direct costs</measure>
    <time_frame>one year</time_frame>
    <description>Direct costs related to each procedure involved on lung cancer</description>
  </primary_outcome>
  <primary_outcome>
    <measure>HRQoL</measure>
    <time_frame>up to 30 days after the procedure</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Preference values</measure>
    <time_frame>cross sectional</time_frame>
    <description>Evaluate preference values in hypothetic scenarios</description>
  </primary_outcome>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Lung Cancer</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Lung cancer patients from Instituto Nacional de Câncer during one year.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of lung cancer disease

          -  Able to understand the overall concept of study and sign the written informed consent

        Exclusion Criteria:

          -  Illiterate

          -  Visible cognitive impaired

          -  Non-primary lung tumor
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carlos Gil Ferreira</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Cancer Institute, France</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Luciene Schluckebier</last_name>
    <role>Study Director</role>
    <affiliation>National Cancer Institute, France</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marisa Santos</last_name>
    <role>Study Chair</role>
    <affiliation>INC</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Bruna Carvalho</last_name>
    <role>Study Chair</role>
    <affiliation>National Cancer Institute, France</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Pedro Masson</last_name>
    <role>Study Chair</role>
    <affiliation>National Cancer Institute, France</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Andréa Monteiro</last_name>
    <role>Study Chair</role>
    <affiliation>INC</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Bruna Medeiros</last_name>
    <role>Study Chair</role>
    <affiliation>INC</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kátia Senna</last_name>
    <role>Study Chair</role>
    <affiliation>INC</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Márcia Gisele</last_name>
    <role>Study Chair</role>
    <affiliation>INC</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Luciene Schluckebier</last_name>
    <phone>552132076660</phone>
    <email>lschluckebier@inca.gov.br</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Alessandra Marins</last_name>
    <phone>55 21 32076569</phone>
    <email>amarins@inca.gov.br</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>INCA - Instituto Nacional de Câncer</name>
      <address>
        <city>Rio de Janeiro</city>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Luciene Schluckebier</last_name>
      <phone>55 21 32076660</phone>
      <email>lschluckebier@inca.gov.br</email>
    </contact>
    <contact_backup>
      <last_name>Alessandra Marins</last_name>
      <phone>55 21 32076569</phone>
      <email>amarins@inca.gov.br</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>March 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 9, 2015</study_first_submitted>
  <study_first_submitted_qc>February 9, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 13, 2015</study_first_posted>
  <last_update_submitted>March 3, 2015</last_update_submitted>
  <last_update_submitted_qc>March 3, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 4, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Instituto Nacional de Cancer, Brazil</investigator_affiliation>
    <investigator_full_name>Carlos Gil Moreira Ferreira</investigator_full_name>
    <investigator_title>MD PHD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

